Chugai Pharmaceuticals Co. Ltd. ADR (Unsponsored)

(CHGCY)

By |

Profile

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly 75%-80% of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines, primarily focused on oncology, renal diseases, and bone and joint diseases. It is an industry leader in antibody technology with several notable therapies, including Hemlibra for hemophilia patients and Actemra for rheumatoid arthritis.

Contact Information

Website: www.chugai-pharm.co.jp
Main Phone: +81 332816611
Address: 1-1 Nihonbashi-Muromachi 2-Chome
Address 2: Nihonbashi Mitsui Tower (Reception15F)
City / Town: Tokyo
Country: JPN
Postal Code: 103-8324

Issuer Information

Exchange: OTO
Employees: 7432
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly 75%-80% of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines, primarily focused on oncology, renal diseases, and bone and joint diseases. It is an industry leader in antibody technology with several notable therapies, including Hemlibra for hemophilia patients and Actemra for rheumatoid arthritis.

Contact Information

Website: www.chugai-pharm.co.jp
Main Phone: +81 332816611
Address: 1-1 Nihonbashi-Muromachi 2-Chome
Address 2: Nihonbashi Mitsui Tower (Reception15F)
City / Town: Tokyo
Country: JPN
Postal Code: 103-8324

Issuer Information

Exchange: OTO
Employees: 7432
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 130.31 $ 0.56 (0.43%)
Last Price 130.31 Change $ 0.56 Change % 0.43 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 130.31 High 130.31 Low 130.31 Prev Close 129.75
Last Trade Volume 1,502 52 Wk Hi 142.77 52 Wk Low 100.88
Market Cap 35.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 273,613,238.00 EPS (TTM) 3.35 PE Ratio 38.70 Exchange OTCPK